Rauf Latif Selected Research

Thyrotropin Receptors (Thyrotropin Receptor)

1/2022	Rescue of thyroid cells from antibody induced cell death via induction of autophagy.
1/2022	Mechanisms in Graves Eye Disease: Apoptosis as the End Point of Insulin-Like Growth Factor 1 Receptor Inhibition.
1/2020	Graves' disease.
1/2019	A Modifying Autoantigen in Graves' Disease.
1/2019	Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival In Vivo.
1/2016	TSH Receptor Signaling Abrogation by a Novel Small Molecule.
1/2015	New small molecule agonists to the thyrotropin receptor.
12/2013	How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.
12/2013	Targeting thyroid diseases with TSH receptor analogs.
8/2011	The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rauf Latif Research Topics

Disease

24	Graves Disease (Basedow Disease) 01/2022 - 12/2002
12	Hyperthyroidism 01/2022 - 06/2004
9	Thyroid Diseases (Thyroid Disease) 10/2014 - 08/2005
4	Graves Ophthalmopathy 01/2022 - 03/2005
4	Thyroid Neoplasms (Thyroid Cancer) 06/2015 - 09/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2012
3	Bone Resorption 09/2012 - 08/2011
3	Thyroiditis 07/2010 - 09/2007
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Exophthalmos (Proptosis) 01/2022 - 07/2012
2	Hypothyroidism 12/2013 - 09/2009
2	Osteoporosis 10/2012 - 08/2011
1	Eye Diseases (Eye Disease) 01/2022
1	Edema (Dropsy) 01/2022
1	Diplopia (Double Vision) 01/2022
1	Teratoma (Teratoid Tumor) 01/2020
1	Fetal Diseases (Embryopathy) 01/2020
1	Hypoparathyroidism 01/2020
1	Thyroid Nodule (Nodule, Thyroid) 10/2014
1	Neoplasms (Cancer) 12/2013
1	Infections 12/2012
1	Disease Susceptibility (Diathesis) 07/2010
1	Goiter 09/2009
1	Myxedema 03/2005

Drug/Important Bio-Agent (IBA)

20	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022 - 12/2002
12	AntibodiesIBA 01/2022 - 08/2005
8	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022 - 03/2008
6	AutoantibodiesIBA 01/2022 - 06/2004
5	Thyroid HormonesIBA 01/2020 - 03/2008
5	AutoantigensIBA 01/2019 - 03/2005
5	AntigensIBA 10/2014 - 12/2002
4	Monoclonal AntibodiesIBA 01/2022 - 11/2004
2	Insulin-Like PeptidesIBA 01/2022 - 01/2020
2	Thyroid-Stimulating ImmunoglobulinsIBA 01/2016 - 01/2016
2	LigandsIBA 01/2015 - 01/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022
1	teprotumumabIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2020
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2020
1	Protein-Arginine DeiminasesIBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2016
1	Molecular Probes (Molecular Probe)IBA 01/2015
1	Messenger RNA (mRNA)IBA 10/2014
1	celastrolIBA 01/2014
1	VimentinIBA 01/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2012
1	IodineIBA 12/2012
1	Hormones (Hormone)IBA 09/2012
1	OsteoprotegerinIBA 09/2011
1	Immunoglobulins (Immunoglobulin)IBA 08/2011
1	MicroRNAs (MicroRNA)IBA 07/2010
1	NucleotidesIBA 07/2010
1	Long-Acting Thyroid Stimulator (LATS)IBA 12/2009
1	Thyroglobulin FDA Link 09/2009
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2009
1	Biological ProductsIBA 06/2009
1	CTLA-4 AntigenIBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 09/2007
1	EpitopesIBA 11/2004
1	Immune Sera (Antisera)IBA 11/2004

Therapy/Procedure

2	Tissue Expansion 01/2022 - 01/2020
2	Therapeutics 01/2020 - 09/2011
1	Transplantation 01/2020
1	Thyroidectomy 10/2014
1	Decompression 07/2012